13F-HR filed by Valence8 US LP
Valence8 US LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-12, with 62 holding rows worth $241,102,218.
- Accession
- 0001172661-24-004545
- Filer
- CIK 1943819
- Filed
- 2024-11-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 62 entries on the cover page, a total value of $241,102,218 stated on the cover page (in dollars after the unit check, H1), rows summing to $241,102,218 with VALUE read as dollars as filed, 13F file number 028-22775. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ISHARES MSCI USA QUALITY FACTOR ETF | 46432F339 | ETF | 337,472 | $60,508,730 | dollars as filed | |
| INVESCO QQQ TR | 46090E103 | COM | 88,149 | $43,022,882 | dollars as filed | |
| ISHARES TR | 46434V456 | MSCI INTL QUALTY | 1,026,290 | $42,580,772 | dollars as filed | |
| iShares MSCI EAFE Value ETF | 464288877 | SHS | 399,186 | $22,965,171 | dollars as filed | |
| Vanguard Value ETF | 922908744 | SHS | 96,630 | $16,868,699 | dollars as filed | |
| SELECT SECTOR SPDR TR | 81369Y308 | STATE STREET CON | 165,267 | $13,717,161 | dollars as filed | |
| ISHARES TR MSCI UK ETF NEW | 46435G334 | MSCI UK ETF NEW | 209,344 | $7,831,559 | dollars as filed | |
| iShares MSCI Japan ETF | 46434G822 | SHS | 108,634 | $7,771,676 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 64,000 | $4,986,240 | dollars as filed | call |
| Utilities Select Sector SPDR Fund | 81369Y886 | SHS | 51,940 | $4,195,713 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 8,969 | $999,236 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 17,785 | $920,196 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 4,585 | $684,586 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 2,000 | $644,420 | dollars as filed | put |
| Amgen Inc. | 031162100 | COM | 2,000 | $644,420 | dollars as filed | call |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 12,500 | $631,125 | dollars as filed | call |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 13,100 | $615,438 | dollars as filed | call |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 7,865 | $574,145 | dollars as filed | |
| Indivior PLC | G4766E116 | Common Stock | 57,293 | $564,186 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 633 | $560,800 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 953 | $516,602 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 9,706 | $490,056 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 6,600 | $481,800 | dollars as filed | call |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 8,025 | $466,012 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 3,900 | $464,373 | dollars as filed | call |
| NUVALENT INC COM | 670703107 | Stock | 4,115 | $420,965 | dollars as filed | |
| FILANA THERAPEUTICS INC | 14817C107 | CMN | 14,100 | $414,963 | dollars as filed | put |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 6,900 | $383,295 | dollars as filed | call |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 13,100 | $377,804 | dollars as filed | call |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 7,857 | $356,944 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 26,200 | $343,613 | dollars as filed | call |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 6,684 | $341,552 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 13,188 | $310,050 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 5,240 | $307,798 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 13,100 | $298,025 | dollars as filed | call |
| VAXCYTE INC COM | 92243G108 | Stock | 2,468 | $282,018 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 4,100 | $274,003 | dollars as filed | call |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 13,020 | $267,561 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 33,650 | $252,039 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 2,618 | $242,165 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 4,241 | $235,588 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 6,500 | $220,935 | dollars as filed | put |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 19,939 | $206,568 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 26,200 | $185,496 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 20,300 | $172,550 | dollars as filed | call |
| ALTIMMUNE INC | 02155H200 | COM NEW | 26,200 | $160,868 | dollars as filed | call |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 21,596 | $149,876 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 23,500 | $144,290 | dollars as filed | put |
| ERASCA INC COM | 29479A108 | Stock | 46,923 | $128,100 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 13,100 | $123,009 | dollars as filed | call |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 15,728 | $109,624 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 2,300 | $104,489 | dollars as filed | put |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 34,376 | $103,472 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 13,100 | $99,560 | dollars as filed | call |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 17,495 | $71,030 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 14,708 | $68,539 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 12,045 | $61,309 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 10,500 | $59,850 | dollars as filed | call |
| CYPHERPUNK TECHNOLOGIES INC | 52187K200 | COM NEW | 18,511 | $47,573 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 26,107 | $33,939 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 20,700 | $20,418 | dollars as filed | call |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 21,136 | $16,342 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-24-004545 | this filing | 2024-11-12 | acceptance time not in the bulk data set |